• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·600381.SS
Share

Qinghai Spring Medicinal Resources Technology Co., Ltd. Stocks

CN¥ 3.7Last Updated 21.07.2026

Issuer Rating

3/7
Performance

Poor

Risk

Limited

Recommendation

Sell

Market Cap

CN¥ 354.79M

CN¥ 3.7
Key Takeaways

Risk factor

Meaningful price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable price performance

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Qinghai Spring Medicinal Resources Technology Co., Ltd. specializes in the research, development, and commercialization of cordyceps products. Its operations further extend to the distribution of beverages and aquatic items, providing advertising solutions, and conducting foreign investment activities. The company was established in 2003 and is headquartered in Xining, China.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is overpriced on P/FCF.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

22.07.2026 14:47

Mythos, Quantum, Slowing Sales: What Are the Main Threats to IBM?

22.07.2026 13:53

The rally in Korean stocks ran out of steam on just the second day. Will FOMO return?

22.07.2026 13:49

Oil prices rose 4%. The U.S. stated that Iran is not taking the negotiations “seriously.”

22.07.2026 13:06

BTIG analysts no longer recommend buying TripAdvisor stock. It's losing out to AI

22.07.2026 12:04

Neuralink's Valuation on the Secondary Market Soared to $42 Billion — Business Insider

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026